| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |